INSP Inspire Medical Systems, Inc.
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for patients with moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.…
Industry Peers
Medical DevicesKey Statistics
About Inspire Medical Systems (NYSE: INSP)
›
Inspire Medical Systems (NYSE: INSP) is listed on the New York Stock Exchange, where its shares trade in USD. It belongs to the Medical Devices industry, part of the Healthcare sector, and reports about 1,333 employees.
The shares were at 56.28 USD on 19 November 2026, down 34.8% over 52 weeks. Its 52-week range is 38.91 USD to 147.03 USD: the price is 61.7% below the high and 44.6% above the low.
At a market capitalisation of 1.63B USD, it trades at 16.8 times trailing earnings and 37.6 times forward earnings. The median trailing P/E of its 19 largest Medical Devices peers is 25.6, a discount of 34% for INSP.
Inspire Medical Systems reports return on equity of 18.6%, an operating margin of 4.5% and revenue down 7.9% year over year.
It holds more cash than debt, a net cash position of 299.36M USD. Its Piotroski F-score is 7 out of 9, a strong reading of its financial health. 16 analysts cover the stock, with an average rating of Hold; their mean price target of 69.38 USD is 23.3% above the current price. The next earnings report is expected on 10 February 2027.